Structure
(C-Type Natriuretic Peptide (CNP)(1-22), human TFA, CAS 1966153-17-2)
FATP1-IN-1 biochemical
FATP1-IN-1
Purity
98%
Synonyms
FATP1-IN-1; N/A; FATP1-IN-1 biochemical
Purity/Purification
98%
CAS
1431945-95-7
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
In vitro
FATP1-IN-1 (p.o.; 10 mg/kg) treatment shows the C max, AUC and T max were 5.5 ug/mL, 36 ug h/mL and 0.33 hours, respectively, and exceeds the mouse IC 50 value of 0.22 uM without considering plasma protein binding. Animal Model: Mouse plasma[1]. Dosage: 10 mg/kg. Administration: P.o. Result: The C max, AUC and T max were 5.5 ug/mL, 36 ug h/mL and 0.33 hours, respectively.
Preparation and Storage
Powder: -20 degree C for 3 years
In solvent: -80 degree C for 2 years
In solvent: -80 degree C for 2 years
Structure
(C-Type Natriuretic Peptide (CNP)(1-22), human TFA, CAS 1966153-17-2)
Structure
(C-Type Natriuretic Peptide (CNP)(1-22), human TFA, CAS 1966153-17-2)
Structure
(C-Type Natriuretic Peptide (CNP)(1-22), human TFA, CAS 1966153-17-2)
Structure
(C-Type Natriuretic Peptide (CNP)(1-22), human TFA, CAS 1966153-17-2)
Related Product Information for FATP1-IN-1 biochemical
FATP1-IN-1 is a fatty acid transport protein 1 (FATP1) inhibitor. FATP1-IN-1 is an inhibition of recombinant human or mouse acyl-CoA synthetase activity of FATP1, with the IC 50 values of 0.046 uM or 0.60 uM, respectively.
References
1. Morozumi N, et al. ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism. PLoS One. 2019 Feb 22;14(2):e0212680.
2. Mazarati AM, et al. ANP(1-28), BNP(1-32) and CNP(1-22) increase the severity of picrotoxin-kindled seizure syndrome in rats. Life Sci. 1993;52(3):PL19-24.
2. Mazarati AM, et al. ANP(1-28), BNP(1-32) and CNP(1-22) increase the severity of picrotoxin-kindled seizure syndrome in rats. Life Sci. 1993;52(3):PL19-24.
Similar Products
Product Notes
The FATP1-IN-1 (Catalog #AAA227707) is a Biochemical and is intended for research purposes only. The product is available for immediate purchase. It is sometimes possible for the material contained within the vial of "FATP1-IN-1, Biochemical" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.